Condition 1: Hemodynamic changes. Condition 2: Bleeding rate. Condition 3: arrhythmia. Cardiac arrhythmia, unspecified
Conditions
Interventions
Intervention 1: Intervention group 1: Patients who met the necessary conditions, after full training by an anesthesiologist and filling in the patient's informed personal consent form, entered the stu
Sponsors
Qazvin University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 60 Years
Inclusion criteria
Inclusion criteria: Willingness to participate in research with informed consent after giving necessary and sufficient explanations about the study The age of the person should be between 15 and 60 years There is no history of surgery and it is the patient's first surgery Not having a chronic mental or physical illness (schizophrenia, diabetes, etc.) Not having vision and hearing problems and other disabilities No allergy to Remifentanil, Profol and Labtalol Absence of pregnancy, breastfeeding and abortion less than 3 months
Exclusion criteria
Exclusion criteria: Heart diseases and HTN Liver diseases (cirrhosis, hepatitis, etc.)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bleeding. Timepoint: First, three minutes after the start of induction, then three and five minutes and then ten minutes. Method of measurement: ECG, pulse oximeter, non-invasive blood pressure measurement. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactKhashayar Shahverdi
Qazvin University of Medical Sciences
Outcome results
None listed